Ben Carson Reveals He Was 'Desperately Ill' With Coronavirus

Clay Curtis
November 23, 2020

Ben Carson, secretary of the Department of Housing and Urban Development, took to Facebook on Friday to report he has been "extremely sick" with the coronavirus.

"In a clinical trial of patients with COVID-19, casirivimab and imdevimab, administered together, were shown to reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression within 28 days after treatment when compared to placebo", the U.S. Food and Drug Administration said in a statement Saturday.

There is no medical evidence that the treatments Carson cited worked. Carson tested positive earlier this month.

But Carson has now revealed that he was "desperately ill" and required experimental treatment to recover from the virus. However, I have several co-morbidities and after a brief period when I only experienced minor discomfort, the symptoms accelerated and I became desperately ill. He elaborated that "President Trump was following my condition and cleared me for the monoclonal antibody therapy that he had previously received, which I am convinced saved my life". HUD also declined to comment.

There are several monoclonal antibody treatments that are in the experimental phase of testing and have not been given an emergency use authorization by the FDA.

Yankees-Red Sox Series Heats up AL East Race
The New York Yankees won the series, winning 8-1, losing 11-0, and winning 11-1 to make up some ground on their rivals. Despite sitting on top for much of the season, the Boston Red Sox are expected to lose steam as the season progresses.

"I do believe I am out of the woods at this point", said the secretary, who gave credit to Trump, the White House medical team and doctors at the Walter Reed military hospital.

The authorization of Regeneron and the finalizing of COVID-19 vaccines from Pfizer and Moderna hopefully means that soon Americans other than those in the Trump orbit will have the benefit of better options for treatment and protection from the novel coronavirus.

The safety and effectiveness of the Regeneron drug have not yet been proven.

The Food and Drug Administration has allowed for the emergency use of of Regeneron's Covid-19 antibody treatment, a step that will make it more widely available to patients.

While grateful for getting excellent medical care, Carson said the country should now focus on making comparable treatments accessible to everyone.

Other reports by

Discuss This Article